Skip to content

Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans

Effect of BurstDR and Tonic Spinal Cord Stimulation (SCS) on Glucose Metabolism in Patients With Neuropathic Pain

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05794776
Enrollment
0
Registered
2023-04-03
Start date
2023-03-16
Completion date
2023-10-01
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Stimulation, Insulin Secretion

Brief summary

This trial investigates the effect of BurstDR and tonic spinal cord stimulation (SCS) on glucose metabolism and heart rate variability in patients with neuropathic pain.

Detailed description

This study investigates the effect of spinal cord stimulation (BurstDR stimulation versus tonic stimulation versus no stimulation) on glucose metabolism, insulin secretion and heart rate variability in patients with neuropathic pain. To assess insulin secretion, hyperglycaemic clamps are performed in 10 patients. Three different stimulation conditions (BurstDR, tonic and no stimulation) are tested in 10 hyperglycaemic clamps each. A total of 30 clamps are carried out.

Interventions

DEVICEBurstDR stimulation

BurstDR spinal cord stimulation

Tonic spinal cord stimulation

Stimulator is switched off

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* implanted BurstDR spinal cord stimulating system * body mass index 18-25 kg/m2

Exclusion criteria

* neurological and psychatric diseases * decompensated diabetes mellitus * hemoglobin \< 13 g/dl * thrombocytopenia

Design outcomes

Primary

MeasureTime frameDescription
First and second phase of insulin secretionInsulinsecretion during clamp (2 hours)Modulation of insulin secretion by spinal cord stimulation

Secondary

MeasureTime frameDescription
Root Mean Square of Successive Differences (RMSSD)Heart rate variablity during stimulation (10 minutes)Modulation of heart rate variability by spinal cord stimulation assessed by electrocardiography

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026